Spider Venom Peptides Offer New Defense Against Varroa Mites Ravaging Honeybee Colonies

Australian researchers isolated peptides Ht1a and Gg1a from spider venoms that kill Varroa destructor mites on contact while leaving honeybees unharmed. The biodegradable compounds target mite nervous systems with high selectivity and show no activity against key human ion channels. Published findings and new grants signal rapid progress toward commercial hive treatments.
Spider Venom Peptides Offer New Defense Against Varroa Mites Ravaging Honeybee Colonies
Written by Victoria Mossi

Honeybee colonies face an unrelenting assault. Varroa destructor mites suck the life from bees and spread viruses that collapse entire hives. Beekeepers have watched chemical treatments lose their punch as resistance builds. Now a team of Australian researchers has turned to an unexpected source for relief. Spider venom.

Scientists screened venom from 50 arachnids and scorpions. More than three-quarters killed varroa mites within a day. Two stood out. Peptides isolated from the Tasmanian cave spider and the Giant Japanese funnel-web spider proved lethal to the parasites. The bees stayed unharmed. The findings, published in npj Drug Discovery, point toward treatments that could sidestep the resistance problems plaguing current acaricides.

Associate Professor Volker Herzig led the work at the University of the Sunshine Coast. His lab holds the world’s largest collection of arachnid venoms. “We screened 50 venoms, mostly from spiders and scorpions, by applying them externally to the mites,” he told the university. “We found more than 75 percent killed the mites within 24 hours. We selected two of the most potent spider venoms for further analysis.”

The peptides earned names Ht1a and Gg1a. Topical application at 0.48 micrograms per mite cut varroa survival dramatically. At doses scaled for body surface area, honeybees showed no ill effects even at 25 micrograms per bee. That safety margin matters. Existing treatments often stress the bees or leave residues in honey.

But why would spider venom target mites? Both belong to the arachnid family. Spiders eat mites in the wild. Their toxins have evolved to disrupt the nervous systems of fellow arachnids. “A spider is an arachnid and a mite is also an arachnid and, because they eat each other, they also have toxins in their venom that target each other,” Herzig explained in an ABC News report.

The peptides act on voltage-gated sodium channels. Ht1a inhibits those channels in both varroa and honeybees with similar potency in lab tests. Yet only the mites died after external application. The exact reason remains under study. Perhaps differences in cuticle penetration or metabolism explain the selectivity. Either way, the outcome is clear. Mites drop. Bees persist.

Human safety looks promising too. Neither peptide affected key human sodium channels or most calcium channels at relevant concentrations. One showed only partial activity at a high dose against a nicotinic receptor. The compounds break down naturally. No buildup in the food chain. No harm to beekeepers, livestock or pets. Herzig calls the approach more organic than synthetic pesticides.

Varroa mites reached Australia in 2022. They have since spread across five states and territories. The invasion threatens a $4.6 billion slice of the nation’s agriculture that depends on bee pollination. Honey production worth $237.5 million sits at risk. Beekeepers already operate on thin margins. Colony losses push many toward exit.

Chemical controls once worked. Resistance changed that. Formic acid, oxalic acid and synthetic acaricides all face challenges with temperature sensitivity, bee toxicity or declining efficacy. Beekeepers need options that integrate into existing practices without disrupting hive chemistry or honey quality. The spider peptides fit that profile. They emerged from a systematic screen rather than a lucky guess.

The paper lists multiple collaborators. Institutions in Queensland, Oslo, Ghent and the Swiss Bee Research Centre contributed expertise. Funding came from an Australian Research Council Future Fellowship awarded to Herzig in 2020. A fresh $50,000 grant from Queensland’s Community Bee Innovation Fund will support the next phase. That money arrives at a critical moment.

Tests so far occurred on individual mites and bees. The team plans to treat hives infested with varroa. They will apply the peptides to colonies and watch outcomes under realistic conditions. Success could lead to a sprayable product. “If that works, then we could design a sprayable treatment,” Herzig said. “The mites will hopefully drop dead and the bees still stay alive.”

Parallel research at the same university explores RNA interference. Professor Rob Harvey aims to silence essential mite genes. Those molecules could act like birth control for varroa or kill them outright. The Queensland government has committed $100,000 across both projects. Officials want solutions ready within years, not decades.

Industry watchers note the urgency. Varroa has already devastated colonies in Europe, North America and parts of Asia. Australia enjoyed a varroa-free status longer than most. That buffer has vanished. Beekeepers report higher winter losses and weaker summer productivity. Pollination contracts grow harder to fulfill.

Herzig’s venom biobank contains samples from more than 870 species. The collection keeps expanding. Each new venom offers another chance to find compounds with narrow toxicity profiles. The current hits came from Hickmania troglodytes and Gigathele gigas. Neither spider poses danger to humans under normal circumstances. Their venom peptides, once synthesized, require no ongoing spider milking for commercial scale.

Production could prove straightforward. Many venom peptides are manufactured through solid-phase synthesis or recombinant methods. Biodegradability reduces environmental persistence. Regulatory pathways for biopesticides often move faster than those for novel synthetic chemicals. Still, questions remain. How stable are the peptides inside a humid hive? Will repeated applications select for resistant mites? How do they interact with other hive treatments?

The research team has begun to address some of these. Electrophysiology data show the mechanism. Toxicology profiles rule out broad harm to vertebrates. Field trials will test practical delivery. A spray that coats frames or a strip that releases compound over time could fit neatly into current integrated pest management programs.

Beekeeping organizations have greeted the news with cautious optimism. They have seen miracle cures before. Many failed in practice. This one carries stronger laboratory backing. The peer-reviewed paper details mortality curves, dose responses and channel assays. Results align with the urgent need for selective, sustainable varroacides.

Global food security hinges on pollinators. One-third of crops rely on bees. Almonds, apples, berries and vegetables all suffer when hives weaken. The economic ripple effects stretch far beyond honey jars. Researchers in Switzerland, Belgium and Norway joined the project because the problem crosses borders.

Herzig emphasizes the peptides’ potential as a commercial product. “These peptides, which we named Ht1a and Gg1a, are fully biodegradable and our findings suggest they could be developed into a commercial, sustainable treatment for varroa mite infestations in honeybee hives,” he said in the UniSC news release.

University leadership sees broader impact. Vice-Chancellor Helen Bartlett highlighted the work’s alignment with sustainability goals. The institution ranked first in Australia for research addressing hunger in recent impact ratings. Protecting bees supports that mission.

So the path forward looks concrete. Refine the formulation. Complete hive-level trials. Gather data for regulatory submission. Meanwhile, beekeepers continue monitoring mite levels with alcohol washes and sticky boards. They rotate existing treatments to slow resistance. Many now view the spider-derived compounds as a promising addition to their arsenal rather than a distant dream.

Challenges persist. Scaling production. Ensuring consistent efficacy across climates. Educating beekeepers on proper use. Yet the core discovery stands. Two small peptides from distant spiders can kill a major bee threat without collateral damage. That selectivity, born from evolutionary arms races in the arachnid world, may soon help bees survive in managed hives worldwide.

And the clock keeps ticking. Each season without better tools brings more colony losses. Each resistant mite population grows harder to manage. The venom peptides offer a targeted strike. Precise. Natural in origin. Backed by rigorous testing. For an industry under pressure, it represents more than an interesting laboratory result. It represents a practical path to protect the insects that feed so much of the planet.

Subscribe for Updates

HealthRevolution Newsletter

By signing up for our newsletter you agree to receive content related to ientry.com / webpronews.com and our affiliate partners. For additional information refer to our terms of service.

Notice an error?

Help us improve our content by reporting any issues you find.

Get the WebProNews newsletter delivered to your inbox

Get the free daily newsletter read by decision makers

Subscribe
Advertise with Us

Ready to get started?

Get our media kit

Advertise with Us